These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18985869)

  • 21. Simultaneous ST-segment elevation in the right precordial and inferior leads in Brugada syndrome.
    Lombardi F; Potenza S; Beltrami A; Verzoni A; Brugada P; Brugada R
    J Cardiovasc Med (Hagerstown); 2007 Mar; 8(3):201-4. PubMed ID: 17312439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Brugada syndrome.
    Escárcega RO; Jiménez-Hernández M; Garcia-Carrasco M; Perez-Alva JC; Brugada J
    Acta Cardiol; 2009 Dec; 64(6):795-801. PubMed ID: 20128157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The SCN5A gene in Brugada syndrome: mutations, variants, missense and nonsense. What's a clinician to do?
    Skinner JR; Love DR
    Heart Rhythm; 2010 Jan; 7(1):50-1. PubMed ID: 20129285
    [No Abstract]   [Full Text] [Related]  

  • 24. Provocation of silence.
    van Opstal JM; Volders PG; Crijns HJ
    Europace; 2009 Mar; 11(3):385-7. PubMed ID: 19181867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brugada syndrome: recent advances and controversies.
    Antzelevitch C; Nof E
    Curr Cardiol Rep; 2008 Sep; 10(5):376-83. PubMed ID: 18715534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Case of ventricular fibrillation in patients with brugada type electrocardiogram during surgery].
    Yatabe T; Hirohashi M; Takeuchi S; Maeda Y; Yamashita K; Yokoyama M
    Masui; 2011 Jun; 60(6):728-32. PubMed ID: 21710774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac toxicity of local anesthetics in the intact isolated heart model: a review.
    Heavner JE
    Reg Anesth Pain Med; 2002; 27(6):545-55. PubMed ID: 12430103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A rare loss-of-function SCN5A variant is associated with lidocaine-induced ventricular fibrillation.
    Xiong Q; Cao L; Hu J; Marian AJ; Hong K
    Pharmacogenomics J; 2014 Aug; 14(4):372-5. PubMed ID: 24445991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Sectio and Brugada syndrome].
    Ammundsen HB; Ekelund K; Afshari A; Albrechtsen CK
    Ugeskr Laeger; 2016 Jul; 178(29):. PubMed ID: 27460467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compound heterozygous SCN5A mutations: does the sum of the parts equal the whole?
    Benson DW
    Heart Rhythm; 2009 Aug; 6(8):1176-7. PubMed ID: 19560406
    [No Abstract]   [Full Text] [Related]  

  • 31. A spontaneous Type 1 electrocardiogram pattern in lead V2 is an independent predictor of ventricular fibrillation in Brugada syndrome.
    Nakano Y; Shimizu W; Ogi H; Suenari K; Oda N; Makita Y; Kajihara K; Hirai Y; Sairaku A; Tokuyama T; Tonouchi Y; Ueda S; Sueda T; Chayama K; Kihara Y
    Europace; 2010 Mar; 12(3):410-6. PubMed ID: 20123697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A sodium channel pore mutation causing Brugada syndrome.
    Pfahnl AE; Viswanathan PC; Weiss R; Shang LL; Sanyal S; Shusterman V; Kornblit C; London B; Dudley SC
    Heart Rhythm; 2007 Jan; 4(1):46-53. PubMed ID: 17198989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A second case with arrhythmogenic cardiomyopathy, provocable Brugada ECG and SCN5A mutation.
    S P
    Int J Cardiol; 2014 Feb; 171(3):e117-8. PubMed ID: 24388542
    [No Abstract]   [Full Text] [Related]  

  • 34. Abnormal restitution property of action potential duration and conduction delay in Brugada syndrome: both repolarization and depolarization abnormalities.
    Nishii N; Nagase S; Morita H; Kusano KF; Namba T; Miura D; Miyaji K; Hiramatsu S; Tada T; Murakami M; Watanabe A; Banba K; Sakai Y; Nakamura K; Oka T; Ohe T
    Europace; 2010 Apr; 12(4):544-52. PubMed ID: 20083482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outward stabilization of the S4 segments in domains III and IV enhances lidocaine block of sodium channels.
    Sheets MF; Hanck DA
    J Physiol; 2007 Jul; 582(Pt 1):317-34. PubMed ID: 17510181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Re: Clinical significance of macroscopic T-wave alternans after sodium channel blocker administration in patients with Brugada syndrome.
    Madias JE
    J Cardiovasc Electrophysiol; 2008 Apr; 19(4):E32; author reply E33. PubMed ID: 18298519
    [No Abstract]   [Full Text] [Related]  

  • 37. Charge at the lidocaine binding site residue Phe-1759 affects permeation in human cardiac voltage-gated sodium channels.
    McNulty MM; Edgerton GB; Shah RD; Hanck DA; Fozzard HA; Lipkind GM
    J Physiol; 2007 Jun; 581(Pt 2):741-55. PubMed ID: 17363383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cardiac sodium channelopathy from bench to bedside].
    Zhang YM; Zhou N
    Zhonghua Er Ke Za Zhi; 2013 Nov; 51(11):874-7. PubMed ID: 24484568
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy of low-dose bepridil for prevention of ventricular fibrillation in patients with Brugada syndrome with and without SCN5A mutation.
    Murakami M; Nakamura K; Kusano KF; Morita H; Nakagawa K; Tanaka M; Tada T; Toh N; Nishii N; Nagase S; Hata Y; Kohno K; Miura D; Ohe T; Ito H
    J Cardiovasc Pharmacol; 2010 Oct; 56(4):389-95. PubMed ID: 20625312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brugada phenotype and prostate cancer.
    Kusano KF
    Circ J; 2009 Jan; 73(1):35-6. PubMed ID: 19110509
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.